Linda N. Liu

57 year

Health Technology

Consumer Services

Profile

Linda N.
Liu worked as a Senior Director at MaxCyte, Inc. from 2000 to 2007.
She then worked as an Executive Director at Amplimmune, Inc. from 2007 to 2015.
Prior to that, she worked as a Senior Scientist at Osiris Therapeutics, Inc. from 1999 to 2000.
Currently, she is working as a Senior Vice President at NextCure, Inc. since 2015.
Dr. Liu completed her undergraduate degree from Wuhan University and her doctorate from The University of Texas at Austin.

Former positions of Linda N. Liu

Companies	Position	End
NEXTCURE, INC.	Chief Tech/Sci/R&D Officer	2022-01-31
Amplimmune, Inc. Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	2015-07-31
MAXCYTE, INC.	Corporate Officer/Principal	2006-12-31
OSIRIS THERAPEUTICS, INC.	Corporate Officer/Principal	1999-12-31

See the detail of Linda N. Liu's experience

Training of Linda N. Liu

Wuhan University	Undergraduate Degree
The University of Texas at Austin	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Linda N. Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
MAXCYTE, INC.	Health Technology
NEXTCURE, INC.	Health Technology

Private companies	2
Osiris Therapeutics, Inc. Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.	Health Technology
Amplimmune, Inc. Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.	Health Technology